Essais liés3clinical trials
VilleYufulocalisation
PaysJapanlocalisation
SourcelocaleCSV/MySQL

Informations

centre

Synchronisé depuis ClinicalTrials.gov — NCT06565195

Ouvrir le site du centre

Essais cliniques associés

3
MoléculeIndication / populationPhaseNCTTitreStatut
LY3962681 Parkinson Phase 1 NCT06565195 PROSPECT-PD — A Clinical Trial of LY3962681 in Healthy Volunteers and in Patients With Parkinson's Disease RECRUITING
Donanemab Alzheimer Phase 3 NCT04437511 A Study of Donanemab (LY3002813) in Participants With Early Alzheimer's Disease (TRAILBLAZER-ALZ 2) ACTIVE_NOT_RECRUITING
Donanemab Alzheimer Phase 2 NCT07589595 A Study of Donanemab (LY3002813) in Participants With Early Cognitive Decline (TRAILBLAZER-ALZ 7) RECRUITING